The recent Chapter 11 bankruptcy filing by Fisker, a once-promising all-electric vehicle startup, adds to a growing list of failed companies in the electric vehicle (EV) industry. Lackluster consumer demand, significant cash burn, operational challenges, and product issues have plagued Fisker, leading to its downfall. The collapse of Fisker follows other SPAC-backed companies such as
Senator Elizabeth Warren has recently accused Federal Reserve Chair Jerome Powell of bowing to pressure from the financial industry. She claims that Powell is advocating for changes to regulations that would decrease the capital large banks are required to hold. Warren’s concern is rooted in the fact that these regulations, known as Basel III, were
The UK is gearing up for a significant shift in weather patterns, with the possibility of a heatwave looming on the horizon. While last year saw record-breaking temperatures in June, this summer started off rather cold and disappointing. However, according to Sky News weather producer Kirsty McCabe, there is a change on the horizon. As
The FDA recently approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. The first option is the PD-1-directed immune checkpoint inhibitor pembrolizumab (Keytruda), which is approved in combination with carboplatin and paclitaxel for patients with either mismatch repair (MMR)-deficient or MMR-proficient disease. The approval was based on the promising results
As the summer of 2024 is officially in full swing, almost 72 million people were under extreme heat warnings according to the National Weather Service. Major cities such as Chicago, St. Louis, Indianapolis, and New York City were included in this warning, signaling the severity of the heat wave. With temperatures soaring above 90 degrees
Eli Lilly has seen a surge in demand for its weight loss and diabetes treatments in recent times, which has led to a significant increase in its revenue. The outgoing Chief Financial Officer, Anat Ashkenazi, highlighted the company’s success in managing the windfall from its diabetes injection Mounjaro and obesity drug Zepbound. This success has